Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Published inAIDS, vol. 21, no. 16, p. 2201-2207
Publication date2007
Abstract
Keywords
- Adult
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- Cohort Studies
- Dideoxynucleosides/ therapeutic use
- Drug Therapy, Combination
- Female
- Genes, MDR
- HIV Infections/ drug therapy/immunology/virology
- HIV Protease Inhibitors/therapeutic use
- HIV-1/genetics
- Humans
- Lamivudine/ therapeutic use
- Male
- Middle Aged
- Mutation
- Prognosis
- Proportional Hazards Models
- RNA, Viral/blood
- Reverse Transcriptase Inhibitors/ therapeutic use
- Switzerland
- Treatment Failure
- Viral Load
- Zidovudine/ therapeutic use
Affiliation
Citation (ISO format)
WOLBERS, Marcel et al. Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. In: AIDS, 2007, vol. 21, n° 16, p. 2201–2207. doi: 10.1097/QAD.0b013e3282efacb1
Main files (1)
Article
Identifiers
- PID : unige:7691
- DOI : 10.1097/QAD.0b013e3282efacb1
- PMID : 18090047
ISSN of the journal0269-9370